DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation
Globenewswire·2026-02-04 14:30
BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial Intelligence (AI), and the École de technologie supérieure (ÉTS) today announced a major federal investment exceeding 1 Million $CAD to accelerate the development of next-generation artificial intelligence for retinal image analysis. The init ...